Cardiovascular Disease (CVD) Risk Factors

Cardiovascular Disease (CVD) encompasses a range of conditions affecting the heart and blood vessels, making it a leading global health concern. Identifying and understanding the risk factors associated with CVD is crucial for prevention and management.

Major modifiable risk factors include smoking, poor diet, physical inactivity, obesity, and excessive alcohol consumption. Lifestyle choices play a pivotal role in the development of CVD, making targeted interventions essential for reducing these risks.

Non-modifiable factors such as age, gender, genetics/family history, and ethnicity also contribute to CVD susceptibility. Acknowledging these factors is vital for tailored prevention strategies and early intervention.

Emerging risk factors like chronic stress, sleep disorders, and inflammatory conditions are gaining recognition for their role in CVD development. Understanding these factors broadens the scope of preventive measures and underscores the importance of holistic healthcare.

The interaction and combination of risk factors often lead to synergistic effects, amplifying the overall risk of CVD. Recognizing the interconnected nature of these factors is crucial for a comprehensive approach to risk assessment and management.

Prevention and management strategies involve lifestyle modifications, including adopting a healthy diet, regular physical activity, and abstaining from harmful habits. Additionally, medication and treatment play a pivotal role, especially in individuals with multiple risk factors.

In conclusion, a multifaceted understanding of CVD risk factors is essential for effective prevention and management. By addressing modifiable and non-modifiable factors, recognizing emerging risks, and considering the interactions between them, individuals and healthcare professionals can work together to mitigate the impact of CVD. A call to action for risk reduction emphasizes the importance of proactive measures in promoting cardiovascular health and overall well-being.
Cardiovascular Disease (CVD) Risk Factors

Cardiovascular Disease Overview and Risk

Cardiovascular disease (CVD) is an encompassing term that includes a wide range of conditions affecting the heart and blood vessels, constituting a significant global health challenge. It spans conditions like coronary heart disease, hypertension, peripheral artery disease, stroke, heart failure, cardiomyopathy, valvular heart disease, and congenital heart disease, making it a multifaceted health concern. A common thread linking these varied conditions is atherosclerosis, the process involving the loss of natural artery elasticity, which is intrinsic to CVD.

Atherothrombotic CVD, primarily manifesting as coronary heart disease and stroke, significantly contributes to the global burden of mortality and disability. Ongoing research continually uncovers new insights into the mechanisms and risk factors associated with these conditions, driving advancements in preventive strategies and treatment modalities. The cardiovascular system, comprised of both the heart and circulatory system, plays a pivotal role in maintaining bodily functions by facilitating the distribution of oxygen and nutrients to cells while eliminating carbon dioxide and other waste products.

Recognizing the complex interplay of genetic and environmental factors in cardiovascular health, there is a growing emphasis on evaluating individual cardiovascular risk. For those with a familial predisposition to premature cardiovascular disease or displaying symptoms indicative of cardiovascular issues, a thorough risk assessment is imperative. This evaluation should consider a range of factors, including ethnicity, smoking history, family cardiovascular disease history, weight, blood pressure, non-fasting lipids, and non-fasting glucose levels. These comprehensive assessments aid in early detection, personalized intervention, and the formulation of effective preventive measures, thus contributing to the ongoing efforts to mitigate the global impact of cardiovascular diseases.
Cardiovascular Disease Overview and Risk

Dyslipidemia

Cardiovascular disease (CVD) is the leading cause of death in both men and women. On average, more than 2,200 Americans lose their lives to cardiovascular disease each day. Most patients had at least one established CV risk factor – hypertension, dyslipidemia and/or diabetes.

The term dyslipidemia refers to a disturbance of the lipid profile, including both hyperlipidemia and hypolipidemia. Dyslipidemia, the hallmark of the metabolic syndrome, includes increased flux of free fatty acids, raised triglycerides, apolipoprotein B, and small dense low-density lipoprotein, and decreased high density lipoprotein cholesterol.

Dyslipidemia has been well established as an independent risk factor for cardiovascular disease. It refers to the following lipid levels:
*Total cholesterol (TC) > 5.2 mmol/L
*High density lipoprotein cholesterol (HDL-C) < 1.0 mmol/L (males) < 1.2 mmol/L (females)
*Triglycerides (TG) > 1.7 mmol/L
*Low density lipoprotein cholesterol (LDL-C) levels

Low HDL cholesterol and hypertriglyceridemia have been found to be independently and significantly related to myocardial infarction/stroke in patients with metabolic syndrome.

Classification of dyslipidemia
*Primary – due to genetic
*Secondary
Dyslipidemia

Heart disease due to deficiency of Vitamin D

Vitamin D, a fat-soluble prohormone, has wide-ranging roles in the regulation of many physiological processes through their interactions with the vitamin D receptors (VDR). It plays a major role in bones and calcium metabolism.

Recent research has linked inadequate vitamin D status to non-skeletal major chronic diseases, especially cardiovascular diseases. Existing data from laboratory studies, epidemiologic and experimental research and prevention trials, suggest that vitamin D reduces the risk of cardiovascular disease.

Through increased renin and angiotensin II synthesis, vitamin D deficiency can increase the production of reactive oxygen species and G protein RhoA, resulting in inhibition of the pathways necessary for intracellular glucose transporter and thus the development of insulin resistance and metabolic syndrome. In addition, direct effects of vitamin D upon smooth muscle calcification and proliferation could contribute to their effects on cardiovascular health.

Studies have also demonstrated a link between vitamin D deficiency and progression of atherothrombosis and vascular calcification. Vitamin D has been found to regulate macrophage maturation and infiltration into the vasculature, subsequently regulating the expression of pro-inflammatory cytokines and adhesion molecules, which are critical components in the progression of atherosclerosis. These findings are also in line with observations that vitamin-D deficient patients have increased plaque instability and incidence of myocardial infarction.

Heart disease due to deficiency of Vitamin D

Hypertensive heart disease

Hypertension is a powerful predictor of cardiovascular mortality and death from all causes. It is a major risk factor for the development of systolic heart failure as well as heart failure in the setting of preserved left ventricular function.

Hypertensive heart disease can be defined as the response of the heart to the afterload imposed on the left ventricle by the progressively increasing arterial pressure and total peripheral resistance.

Severe hypertension may directly damage arterioles and cause atherosclerosis. High blood pressure is also a risk for stroke.

The risk of cardiovascular events is increased two or three times in men and women with hypertension. It is estimated that 14% deaths from coronary heart disease in men and 12% of deaths from coronary heart disease in women are due to hypertension.

Hypertensive heart disease is characterized by increased left ventricular mass leading to left ventricular hypertrophy in the absence of aortic stenosis or hypertrophic cardiomyopathy. Other manifestations include diastolic dysfunction and microvascular changes that cause coronary blood flow abnormalities.

Left ventricular hypertrophy increases the rletaove risk for amrtlaity by twofold in subjects with coronary artery disease and by four fold in those with normal epicardial coronary arteries.

In the development of hypertensive heart disease, myocyte hypertrophy is also associated with apoptosis, collagen deposition, a ventricular fibrosis, with as impairment of coronary hemodynamics as well, thus profoundly influencing functional properties of the left ventricle.
Hypertensive heart disease

Diabetes and cardiovascular disease

Cardiovascular disease is a common cause of morbidity and mortality in people with diabetes. About 75 percent of people with diabetes die from heart disease or stroke.

Abnormalities in the concentration of lipids and lipoprotein in plasma have been reported to occur in almost 30% of persons with diabetes.

The risk for cardiovascular disease is directly proportional to the concentration of low-density lipoprotein (LDL) cholesterol and inversely proportional to the concentration of high density lipoprotein cholesterol. 

Several epidemiologic studies have shown repeatedly that individuals with diabetes have a high risk of cardiovascular disease in individuals without diabetes.

These suggest that men have a 2-3 fold higher risk of cardiovascular mortality than non-diabetic people. The relative risk is greater for women who have a 4-5 fold higher risk of cardiovascular mortality than their non-diabetic counterparts.

Diabetes is also a poor prognostic factor post myocardial infarction (MI); diabetic patients have a higher inhospitable mortality and post discharge mortality than non-diabetic patients, and a higher risk of infarct-related complications.

Middle age people with type 2 diabetes have the same high risk for heart attack as people without diabetes who already have had a heart attack.

Type 1 which is characterized by an absolute loss of beta cells such that there is almost a total absence of insulin secretion, the patients have increased cardiovascular risk factors as a consequence of their hyperglycemia.

Patients with type 1 diabetes may develop nephropathy as a consequence of poor glycemic control. In the early stages of diabetic nephropathy, thickening of the glomerulus occurs.

The increase in blood pressure and hyperlipidemia that result from diabetic nephropathy is responsible for a significant proportion of the increased risk. Diabetic nephropathy is a major predictor of premature death among Type 1 patients.
Diabetes and cardiovascular disease

Cardiovascular disease

Cardiovascular disease is a general term that includes heart attacks, heart failure, stroke and peripheral artery diseases.

The term cardiovascular diseases broadly encompasses several conditions to the heart and blood vessels, including coronary heart disease, hypertension, peripheral artery disease, stroke, heart failure, cardiomyopathy, valvular heart disease, and congenital heart disease.

The common factor in all types of cardiovascular disease, CVD is the loss of the natural elasticity of the arteries a condition referred to as atherosclerosis.

Atherothrombotic CVD primarily coronary heart disease, and stroke, is the principally contributor to the global burden of mortality and disability.

The heart and circulatory system together make up cardiovascular system, which accomplishes the complex function of distribution oxygen and other nutrients to body cells, as well as carrying away carbon dioxide and other waste products of cellular function for elimination.

Cardiovascular risk should be estimated in people with a family history of premature cardiovascular disease or with symptoms suggestive of cardiovascular disease.

This should include ethnicity, smoking history, family history of cardiovascular disease eight and waist measurements, blood pressure, non-fasting lipids, non fasting glucose.
Cardiovascular disease